In our PM, the data for an endpoint are reported only for baseline and the final timepoint (example, Week 52). There is no mention of interim timepoints in the PM. However, the trial publication contains a chart showing the data for the interim time points (example, every 2 weeks) - would it be acceptable to include these charts, with the interim time points, in a branded, HCP-directed piece?
K
kbernard
@kbernard
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.